CIK 0001808898 · Non-accelerated filer<br>Smaller reporting company
Benitec Biopharma Inc.
Sign in to watch- Ticker
- BNTC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- Phone
- (510) 780-0819
- Business address
- 3940 TRUST WAY, HAYWARD, CA, 94545
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-29 | BUCHI J KEVIN Director | Gift | −51,813 | 52,097 | ||
| 2026-05-26 | Friedman David Matthew Director | Grant or award · Options (right to buy) | +35,000 | 35,000 | ||
| 2026-01-22 | Mates Sharon Director | Grant or award · Options (right to buy) | +31,500 | 31,500 | ||
| 2025-12-29 | SUVRETTA CAPITAL MANAGEMENT, LLC Director | Purchase | +65,800 | $13.44 | $884K | 9,700,195 |
| 2025-12-29 | SUVRETTA CAPITAL MANAGEMENT, LLC Director | Purchase | +11,587 | $13.44 | $156K | 1,848,156 |
| 2025-12-26 | SUVRETTA CAPITAL MANAGEMENT, LLC Director | Purchase | +14,320 | $13.10 | $188K | 9,634,395 |
| 2025-12-26 | SUVRETTA CAPITAL MANAGEMENT, LLC Director | Purchase | +2,516 | $13.10 | $33K | 1,836,569 |
| 2025-12-23 | SUVRETTA CAPITAL MANAGEMENT, LLC Director | Purchase | +42,600 | $12.85 | $547K | 9,620,075 |
| 2025-12-23 | SUVRETTA CAPITAL MANAGEMENT, LLC Director | Purchase | +7,400 | $12.85 | $95K | 1,834,053 |
| 2025-12-22 | SUVRETTA CAPITAL MANAGEMENT, LLC Director | Purchase | +16,650 | $12.08 | $201K | 9,577,475 |
| 2025-12-22 | SUVRETTA CAPITAL MANAGEMENT, LLC Director | Purchase | +2,892 | $12.08 | $35K | 1,826,653 |
| 2025-12-19 | SUVRETTA CAPITAL MANAGEMENT, LLC Director | Purchase | +13,950 | $11.48 | $160K | 9,560,825 |
| 2025-12-19 | SUVRETTA CAPITAL MANAGEMENT, LLC Director | Purchase | +2,434 | $11.48 | $28K | 1,823,761 |
| 2025-12-18 | SUVRETTA CAPITAL MANAGEMENT, LLC Director | Purchase | +8,700 | $11.24 | $98K | 9,546,875 |
| 2025-12-18 | SUVRETTA CAPITAL MANAGEMENT, LLC Director | Purchase | +1,515 | $11.24 | $17K | 1,821,327 |
| 2025-12-01 | Mates Sharon Director | Grant or award · Options (right to buy) | +3,500 | 3,500 | ||
| 2025-12-01 | Mehta Kishan Director | Grant or award · Options (right to buy) | +35,000 | 35,000 | ||
| 2025-12-01 | Smith Edward F Director | Grant or award · Options (right to buy) | +35,000 | 35,000 | ||
| 2025-12-01 | Francis Peter Director | Grant or award · Options (right to buy) | +35,000 | 35,000 | ||
| 2025-12-01 | BUCHI J KEVIN Director | Grant or award · Options (right to buy) | +35,000 | 35,000 |
Page 1 of 5 · 90 trades